AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.

Name: Αlpha¹ Rigor Record — AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.
Item: AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.
Rating: 94
Author: Αlpha¹

Woznitza N, Smith L, Rawlinson J, Au-Yong I, George B, Djearaman MG, Nair A, Lee RW, Navani N, Ndwandwe S, Clarke CS, Creeden A, Newsome J, Das I, Abaokporo S, Tucker R, Hathorn J, Baldwin DR

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 4.25★ (Strong), 0 critical, 3 high issues for “AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 10, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

4.25 / 5

Strong — minor issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern−0.5★
ReportingBiological variables partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.29.0Source: full text

Problems surfaced3 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions1

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Conclusions only partially backed by the presented evidenceAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Biological variables underreported (sex, age, strain)Assessed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

This published RCT evaluating AI-driven prioritization of chest X-rays is methodologically robust with a well-described randomized design, thorough reporting of statistical analyses, and transparent data/code availability. The main weakness is incomplete reporting of baseline demographics (race/ethnicity, comorbidities) and a minor internal inconsistency in Table 5 that should be clarified.

Evaluated using full-text review, two independent automated rigor audits, a copyedit pass, and verification components (citation, statistics, reproducibility, preregistration, integrity, claim audit). The reviewers diverged on biological variables (pass vs. warn); the synthesized status accounts for the more stringent checklist sub-criteria. Statistical recomputation covered 3 tests that were all consistent; coverage is limited to tests with test statistics + df or effect estimates + CI. No retracted or unfindable references were found.

9 major claims checked against the paper's own evidence: all adequately supported.

Recomputed 3 tests: 3 consistent, 0 inconsistent; 3 via agent-written checks.

1 integrity concern flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

Introduction cites UK lung cancer survival, pathway delay evidence, NOLCP guidance, and a prior study showing radiographer CXR reporting reduced time to diagnosis. The premise that AI prioritization of abnormal CXRs could accelerate diagnosis is supported logically, with weaknesses of prior evidence acknowledged (NICE found insufficient evidence for CXR AI).

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 95% conf

The paper establishes a clear premise based on prior literature, including the prior work by the study team, and links the rationale to the trial objectives and hypothesis.

Evidence

paraphrase[Introduction, paragraph 4]

“However, a recent review of the clinical utility of this technology by NICE concluded that there was insufficient evidence to make any recommendations other than to ensure products were carefully evaluated.”

direct quote[Introduction, paragraph 5]

“The primary aim of the trial was to measure the impact of immediate AI-driven prioritization of abnormal CXRs for reporting on the time to CT and diagnosis of lung cancer.”